Patents by Inventor Rolf Dach
Rolf Dach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8993778Abstract: A process for preparing telmisartan by reacting 2-n-propyl-4-methyl-6-(1?-methylbenzimidazol-2?-yl)benzimidazole with a compound of formula (IV) wherein Z is a leaving group, to obtain the compound 2-cyano-4?-[2?-n-propyl-4?-methyl-6?-(1??-methylbenzimidazol-2??-yl)benzimidazol-1?-ylmethyl]biphenyl, and subsequently hydrolyzing the nitrile function to obtain the acid function.Type: GrantFiled: January 25, 2013Date of Patent: March 31, 2015Assignee: Boehringer Ingelheim International GmbHInventors: Norbert Hauel, Rolf Dach, Helmut Heitger, Oliver Meyer
-
Patent number: 8993770Abstract: An improved process for preparing dabigatran etexilate, as well as analogous compounds of formula 7, is described.Type: GrantFiled: February 15, 2013Date of Patent: March 31, 2015Assignee: Boehringer Ingelheim International GbmHInventors: Frieder Gnad, Stefan Schmitt, Hermann Mueller-Boetticher, Helmut Heitger, Seigfried Meineck, Rolf Dach, Ingo Heddesheimer
-
Publication number: 20130303760Abstract: Subject of the present invention is a new improved process for the preparation of nitroorotic acid via nitration of orotic acid.Type: ApplicationFiled: July 18, 2013Publication date: November 14, 2013Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGInventors: Rolf DACH, Xiangrui JIANG, Jingshan SHEN, Jin SUO, Yi ZHU
-
Patent number: 8513413Abstract: Subject of the present invention is a new improved process for the preparation of nitroorotic acid via nitration of orotic acid.Type: GrantFiled: February 22, 2010Date of Patent: August 20, 2013Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Rolf Dach, Xiangrui Jiang, Jingshan Shen, Jin Suo, Yi Zhu
-
Publication number: 20130158270Abstract: An improved process for preparing dabigatran etexilate, as well as analogous compounds of formula 7, is described.Type: ApplicationFiled: February 15, 2013Publication date: June 20, 2013Applicant: Boehringer Ingelheim International GmbHInventors: Frieder GNAD, Stefan SCHMITT, Hermann MUELLER-BOETTICHER, Helmut HEITGER, Seigfried MEINECK, Rolf DACH, Ingo HEDDESHEIMER
-
Publication number: 20130137878Abstract: A process for preparing telmisartan by reacting 2-n-propyl-4-methyl-6-(1?-methylbenzimidazol-2?-yl)benzimidazole with a compound of formula (IV) wherein Z is a leaving group, to obtain the compound 2-cyano-4?-[2?-n-propyl-4?-methyl-6?-(1??-methylbenzimidazol-2??-yl)benzimidazol-1?-ylmethyl]biphenyl, and subsequently hydrolyzing the nitrile function to obtain the acid function.Type: ApplicationFiled: January 25, 2013Publication date: May 30, 2013Applicant: Boehringer Ingelheim International GmbHInventors: Norbert HAUEL, Rolf DACH, Helmut HEITGER, Oliver MEYER
-
Patent number: 8399678Abstract: An improved process for preparing dabigatran etexilate, as well as analogous compounds of formula 7, is described.Type: GrantFiled: November 4, 2010Date of Patent: March 19, 2013Assignee: Boehringer Ingelheim International GmbHInventors: Frieder Gnad, Stefan Schmitt, Hermann Mueller-Boetticher, Helmut Heitger, Siegfried Meineck, Rolf Dach, Ingo Heddesheimer
-
Patent number: 8263788Abstract: The invention relates to a method for producing 1,3-dioxolane-2-ones of general formula (3) in basic reaction conditions by reesterifying the respective ester of general formula (1) in which R1 to R5 have the meanings indicated in the claims and the description. The invention further relates to a method for producing 2-hydroxy carboxylic acid esters of general formula (5) with or without isolation of the intermediate in the form of a derivative of the 1,3-dioxolane-2-one of general formula (3) in basic reaction conditions by reesterifying the respective ester of general formula (1) in which R1, R2, and R6 have the meanings indicated in the claims and the description. The method according to the invention allows the reaction to take place in very gentle basic conditions, causing fewer secondary reactions and providing a greater yield than reactions in highly polar aprotic solvents. Acid-sensitive and/or temperature-sensitive compounds can be synthesized.Type: GrantFiled: September 3, 2008Date of Patent: September 11, 2012Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Joerg Brandenburg, Rolf Dach, Hanfried Baltes
-
Publication number: 20120123118Abstract: Subject of the present invention is a new improved process for the preparation of nitroorotic acid via nitration of orotic acid.Type: ApplicationFiled: February 22, 2010Publication date: May 17, 2012Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH & CO. KGInventors: Rolf Dach, Xiangrui Jiang, Jingshan Shen, Jin Suo, Yi Zhu
-
Publication number: 20110275824Abstract: An improved process for preparing dabigatran etexilate, as well as analogous compounds of formula 7, is described.Type: ApplicationFiled: November 4, 2010Publication date: November 10, 2011Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBHInventors: Frieder GNAD, Stefan SCHMITT, Hermann MUELLER-BOETTICHER, Helmut HEITGER, Siegfried MEINECK, Rolf DACH, Ingo HEDDESHEIMER
-
Publication number: 20100305146Abstract: The invention relates to a method for producing 1,3-dioxolane-2-ones of general formula (3) in basic reaction conditions by reesterifying the respective ester of general formula (1) in which R1 to R5 have the meanings indicated in the claims and the description. The invention further relates to a method for producing 2-hydroxy carboxylic acid esters of general formula (5) with or without isolation of the intermediate in the form of a derivative of the 1,3-dioxolane-2-one of general formula (3) in basic reaction conditions by reesterifying the respective ester of general formula (1) in which R1, R2, and R6 have the meanings indicated in the claims and the description. The method according to the invention allows the reaction to take place in very gentle basic conditions, causing fewer secondary reactions and providing a greater yield than reactions in highly polar aprotic solvents. Acid-sensitive and/or temperature-sensitive compounds can be synthesized.Type: ApplicationFiled: September 3, 2008Publication date: December 2, 2010Applicant: BOEHRINGER INGELHEIM PHARMA GMBH & CO. KGInventors: Joerg Brandenburg, Rolf Dach, Hanfried Baltes
-
Patent number: 7608722Abstract: A process for preparing 1,7?-dimethyl-2?-propyl-2,5?-bi-1H-benzimidazole of formula (I) reacting N-methyl-o-phenylenediamine of formula (II) or the salts thereof with 2-propyl-4-methyl-1H-benzimidazole-6-carboxylic acid of formula (III) or the salts thereof wherein the coupling and cyclization is achieved using 1,3,5-triazine and tertiary amine.Type: GrantFiled: July 12, 2006Date of Patent: October 27, 2009Assignee: Boehringer Ingelheim International GmbHInventors: Helmut Heitger, Juan M. Rodriguez-Dehli, Rolf Dach
-
Patent number: 7193089Abstract: A process for preparing telmisartan by reacting 2-n-propyl-4-methyl-6-(1?-methylbenzimidazol-2?-yl)benzimidazole with a compound of formula (IV) wherein Z is a leaving group, to obtain the compound 2-cyano-4?-[2?-n-propyl-4?-methyl-6?-(1??-methylbenzimidazol-2??-yl)benzimidazol-1?-ylmethyl]biphenyl, and subsequently hydrolyzing the nitrile function to obtain the acid function.Type: GrantFiled: March 17, 2004Date of Patent: March 20, 2007Assignee: Boehringer Ingelheim International GmbHInventors: Norbert Hauel, Rolf Dach, Helmut Heitger, Oliver Meyer
-
Publication number: 20070037986Abstract: A process for preparing 1,7?-dimethyl-2?-propyl-2,5?-bi-1H-benzimidazole of formula (I) reacting N-methyl-o-phenylenediamine of formula (II) or the salts thereof with 2-propyl-4-methyl-1H-benzimidazole-6-carboxylic acid of formula (III) or the salts thereof wherein the coupling and cyclization is achieved using 1,3,5-triazine and tertiary amine.Type: ApplicationFiled: July 12, 2006Publication date: February 15, 2007Inventors: Helmut Heitger, Juan Rodriguez-Dehli, Rolf Dach
-
Publication number: 20040236113Abstract: A process for preparing telmisartan by reacting 2-n-propyl-4-methyl-6-(1′-methylbenzimidazol-2′-yl)benzimidazole with a compound of formula (IV) 1Type: ApplicationFiled: March 17, 2004Publication date: November 25, 2004Applicant: Boehringer Ingelheim International GmbHInventors: Norbert Hauel, Rolf Dach, Helmut Heitger, Oliver Meyer
-
Publication number: 20040225129Abstract: Disclosed is a process which can be used on an industrial scale for preparing and purifying 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole in which the crude product is subjected to charcoal treatment.Type: ApplicationFiled: June 14, 2004Publication date: November 11, 2004Applicant: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Werner Belzer, Rolf Dach, Volker Fachinger, Markus Heitzmann, Hartmut Schmidt
-
Patent number: 6770762Abstract: Disclosed is a process which can be used on an industrial scale for preparing and purifying 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole in which the crude product is subjected to charcoal treatment.Type: GrantFiled: January 16, 2003Date of Patent: August 3, 2004Assignee: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Werner Belzer, Rolf Dach, Volker Fachinger, Markus Heitzmann, Hartmut Schmidt
-
Publication number: 20030139608Abstract: Disclosed is a process which can be used on an industrial scale for preparing and purifying 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole in which the crude product is subjected to charcoal treatment.Type: ApplicationFiled: January 16, 2003Publication date: July 24, 2003Applicant: Boehringer Ingelheim Pharma GmbH & Co. KGInventors: Werner Belzer, Rolf Dach, Volker Fachinger, Markus Heitzmann, Hartmut Schmidt
-
Patent number: 6403790Abstract: A process for preparing epinastine hydrochloride of formula (I) the process comprising: (a) suspending and dissolving an epinastine base of formula (II) in water by the addition of aqueous hydrochloric acid at a pH of ≧7; (b) extracting the aqueous solution obtained from step (a) with an organic, water-immiscible solvent; (c) removing the organic, water-immiscible solvent from the aqueous solution obtained from step (b); and (d) adjusting the pH of the aqueous solution of step (c) to ≦6 using hydrochloric acid to precipitate the product of formula (I), and then drying the product.Type: GrantFiled: November 20, 2000Date of Patent: June 11, 2002Assignee: Boehringer Ingelheim Pharma KGInventor: Rolf Dach
-
Patent number: 5510484Abstract: The present invention relates to an improved process for preparing 1,3-dimethyl-4,5-diaminouracil by catalytic reduction of 1,3-dimethyl-4-amino-5-nitrosouracil in the presence of a palladium/charcoal catalyst.Type: GrantFiled: April 7, 1994Date of Patent: April 23, 1996Assignee: Boehringer Ingelheim KGInventors: Rolf Dach, Wilfried Goldschmidt